Ahmad Arzouni

Ahmad Arzouni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ahmad Arzouni has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Ali Madani

    Rammal Rammal Laboratory, ATAC Group, Faculty of Sciences, Lebanese University, Al-Hadath Campus, Beirut 1003, Lebanon

    1 shared publication
  • Camilla Piazzai

    Department of Science, University of Rome Tre, 00146 Rome, Italy

    1 shared publication
  • Elisa Lanza

    Clinica Medica ‘A. Murri’, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari ‘Aldo Moro’ Medical School, Piazza Giulio Cesare, 11, 70124 Bari, Italy

    1 shared publication
  • Laura Mahdi

    Clinica Medica ‘A. Murri’, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari ‘Aldo Moro’ Medical School, Piazza Giulio Cesare, 11, 70124 Bari, Italy

    1 shared publication
  • Maria Marino

    Department of Science, University Roma Tre, Rome, Italy

    1 shared publication
  • Mohamad Khalil

    Internal Medicine Clinica Medica “A. Murri”, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari ‘Aldo Moro’, 70121 Bari, Italy

    1 shared publication

Latest Publications

  • Open Access

    Neuroglobin: A New Player in the Gut–Brain Axis

    by Mohamad Khalil, Laura Mahdi, Ali Madani, Ahmad Arzouni, Elisa Lanza, Camilla Piazzai, Maria Marino, Piero Portincasa

    Neuroglobin (NGB), initially identified for its oxygen-binding capacity in neuronal tissues, has emerged as a multifunctional protein involved in neuroprotection, oxidative stress regulation, and mitochondrial homeostasis. Although its functions have been extensively studied in the central nervous system (CNS), its potential role in the gut–brain axis (GBA) remains largely unexplored. The GBA integrates neural, endocrine, immune, and metabolic signaling between the gastrointestinal tract and the brain, and growing evidence from microbiome, neurobiology, endocrinology, and nutrition research suggests that several pathways involved in GBA signaling may also influence NGB expression or activity. However, direct experimental evidence, particularly from in vivo studies, remains limited. This hypothesis-driven review integrates evidence from diverse fields to explore the possibility that NGB may represent a molecular link between gut-derived signals and neuroprotective mechanisms. We summarize current knowledge of NGB biology and discuss indirect evidence indicating that microbial metabolites, dietary phytochemicals, and hormonal mediators, including estradiol, may converge on pathways associated with NGB regulation. Based on these observations, we propose a conceptual framework in which NGB could participate in gut–brain communication while emphasizing that this hypothesis requires experimental validation. By bringing together findings that have not previously been considered within a unified context, this review highlights key knowledge gaps, opens new perspectives on the potential involvement of NGB in the GBA, and provides a foundation for future mechanistic studies in neurodegenerative and neuroinflammatory disorders.